Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency

Southern Medical Journal

Volumn 101, Issue 5, 2008, Pages 543-545

  Chan, Joseph S ^a   Harding, Cary O ^a   Blanke, Charles D ^a,b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b University of British Columbia ^*  (United States)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chemotherapy; Hepatocellular carcinoma; Hyperammonemia; Ornithine transcarbamoylase deficiency

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ALPHA2B INTERFERON; AMMONIA; ARGININE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CISPLATIN; CITRULLINE; DOXORUBICIN; FLUOROURACIL; GLUTAMINE; HYDROCODONE; LACTULOSE; ORNITHINE; OROTIC ACID;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; AGITATION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMINO ACID ANALYSIS; AMMONIA BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BRAIN DISEASE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; DISORIENTATION; DRUG DOSE TITRATION; ELECTROENCEPHALOGRAM; ENZYME DEFICIENCY; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; HYPERAMMONEMIA; INTERNATIONAL NORMALIZED RATIO; LEUKOCYTE COUNT; LIVER BIOPSY; LIVER CELL CARCINOMA; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER METASTASIS; LYMPH NODE METASTASIS; MENTAL HEALTH; METABOLIC ENCEPHALOPATHY; MYOCLONUS SEIZURE; NEUROLOGIC EXAMINATION; TOXICITY TESTING; URINALYSIS;

ADULT; ARGININE; CARCINOMA, HEPATOCELLULAR; CITRULLINE; FEMALE; GLUTAMINE; HEPATIC ENCEPHALOPATHY; HUMANS; HYPERAMMONEMIA; LIVER NEOPLASMS; ORNITHINE; ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY DISEASE; OROTIC ACID; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SYNDROME;

EID: 43149106465     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e31816bf5cc     Document Type: Article

References (13)

1. Riordan SM, Williams R. Treatment of hepatic encephalopathy. N Engl J Med 1997;337:473-479.
2. Mitchell RB, Wagner JE, Karp JE, et al. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: review of nine cases. Am J Med 1988;85:662-667.
3. Yeo W, Mok TS, Zee B, et al. A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil combination chemotherapy for unresectable hepatocellular carcinoma. J Natl Cancer Inst 2005;97:1532-1538.
4. Goodman SI, Frerman FE. The Metabolic and Molecular Bases of Inherited Disease 2000, ed 7 New York, McGraw-Hill.
5. Lee JC, Chen MJ, Chang CH, et al. Plasma amino acid levels in patients with colorectal cancers and liver cirrhosis with hepatocellular carcinoma. Hepatogastroenterology 2003;50:1269-1273.
6. Kim YA, Chung HC, Choi HJ, et al. Intermediate dose 5-fluorouracil- induced encephalopathy. Jpn J Clin Oncol 2006;36:55-59.
7. Lukaschek J, Nufer M, Maurer D, et al. Cardiotoxicity and neurotoxicity of high-dose continuous fluorouracil as a result of degradation compounds in the drug vials. J Clin Oncol 2004;22:5022-5025.
8. Yeh KH, Cheng AL. High-dose 5-fluorouracil infusional therapy is associated with hyperammonaemia, lactic acidosis and encephalopathy. Br J Cancer 1997;75:464-465.
9. Yamaguchi S, Brailey LL, Morizono H, et al. Mutations and polymorphisms in the human ornithine transcarbamylase gene. Hum Mutat 2006;27:626-632.
10. Winter SS, Rose E, Katz R. Hyperammonemia after chemotherapy in an adolescent with hepatocellular carcinoma. J Pediatr Gastroenterol Nutr 1997;25:537-540.
11. Jeffers LJ, Dubow RA, Zieve L, et al. Hepatic encephalopathy and orotic aciduria associated with hepatocellular carcinoma in a noncirrhotic liver. Hepatology 1988;8:78-81.
12. Bresnick E, Mayfield ED Jr, Liebelt AG, et al. Enzyme patterns in a group of transplantable mouse hepatomas of different growth rates. Cancer Res 1971;31:743-751.
13. Weber G, Queener SF, Morris HP. Imbalance in ornithine metabolism in hepatomas of different growth rates as expressed in behavior of L-ornithine carbamyl transferase activity. Cancer Res 1972;32:1933-1940.